A Polymer for Application as a Matrix Phase in a Concept of In Situ Curable Bioresorbable Bioactive Load-Bearing Continuous Fiber Reinforced Composite Fracture Fixation Plates

dc.bibliographicCitation.firstPage1256eng
dc.bibliographicCitation.issue5eng
dc.bibliographicCitation.volume26eng
dc.contributor.authorPlyusnin, Artem
dc.contributor.authorHe, Jingwei
dc.contributor.authorElschner, Cindy
dc.contributor.authorNakamura, Miho
dc.contributor.authorKulkova, Julia
dc.contributor.authorSpickenheuer, Axel
dc.contributor.authorScheffler, Christina
dc.contributor.authorLassila, Lippo V. J.
dc.contributor.authorMoritz, Niko
dc.date.accessioned2022-03-29T11:34:21Z
dc.date.available2022-03-29T11:34:21Z
dc.date.issued2021
dc.description.abstractThe use of bioresorbable fracture fixation plates made of aliphatic polyesters have good potential due to good biocompatibility, reduced risk of stress-shielding, and eliminated need for plate removal. However, polyesters are ductile, and their handling properties are limited. We suggested an alternative, PLAMA (PolyLActide functionalized with diMethAcrylate), for the use as the matrix phase for the novel concept of the in situ curable bioresorbable load-bearing composite plate to reduce the limitations of conventional polyesters. The purpose was to obtain a preliminary understanding of the chemical and physical properties and the biological safety of PLAMA from the prospective of the novel concept. Modifications with different molecular masses (PLAMA-500 and PLAMA-1000) were synthesized. The efficiency of curing was assessed by the degree of convergence (DC). The mechanical properties were obtained by tensile test and thermomechanical analysis. The bioresorbability was investigated by immersion in simulated body fluid. The biocompatibility was studied in cell morphology and viability tests. PLAMA-500 showed better DC and mechanical properties, and slower bioresorbability than PLAMA-1000. Both did not prevent proliferation and normal morphological development of cells. We concluded that PLAMA-500 has potential for the use as the matrix material for bioresorbable load-bearing composite fracture fixation plates.eng
dc.description.versionpublishedVersioneng
dc.identifier.urihttps://oa.tib.eu/renate/handle/123456789/8439
dc.identifier.urihttps://doi.org/10.34657/7477
dc.language.isoengeng
dc.publisherBasel : MDPIeng
dc.relation.doihttps://doi.org/10.3390/molecules26051256
dc.relation.essn1420-3049
dc.relation.ispartofseriesMolecules : a journal of synthetic chemistry and natural product chemistry 26 (2021), Nr. 5eng
dc.rights.licenseCC BY 4.0 Unportedeng
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/eng
dc.subjectBioresorbable composite matrixeng
dc.subjectBioresorbable frceng
dc.subjectFunctionalized polylactideeng
dc.subjectLessrigid fracture fixationeng
dc.subjectLight curable polymereng
dc.subject.ddc540eng
dc.titleA Polymer for Application as a Matrix Phase in a Concept of In Situ Curable Bioresorbable Bioactive Load-Bearing Continuous Fiber Reinforced Composite Fracture Fixation Plateseng
dc.typearticleeng
dc.typeTexteng
dcterms.bibliographicCitation.journalTitleMolecules : a journal of synthetic chemistry and natural product chemistryeng
tib.accessRightsopenAccesseng
wgl.contributorIPFeng
wgl.subjectChemieeng
wgl.typeZeitschriftenartikeleng
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
A_polymer_for_application_as_a_matrix_phase.pdf
Size:
2.83 MB
Format:
Adobe Portable Document Format
Description:
Collections